HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norihisa Ishimura Selected Research

Cytokines

11/2017Serum Biomarkers for the Diagnosis of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis.
1/2012Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis.
7/2011Administration of PPARβ/δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practice.
10/2006Increased expression of midkine in the rat colon during healing of experimental colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norihisa Ishimura Research Topics

Disease

10Gastroesophageal Reflux (GERD)
01/2022 - 12/2008
10Eosinophilic Esophagitis
01/2021 - 01/2012
10Barrett Esophagus (Barrett's Esophagus)
03/2016 - 01/2004
9Neoplasms (Cancer)
05/2022 - 01/2004
7Inflammation (Inflammations)
01/2021 - 05/2005
5Colitis
05/2022 - 04/2003
5Peptic Esophagitis (Reflux Esophagitis)
01/2022 - 06/2007
5Infections
02/2021 - 04/2003
5Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
05/2018 - 08/2013
4Dyspepsia (Indigestion)
05/2023 - 01/2009
4Pathologic Constriction (Stenosis)
07/2021 - 01/2018
4Eosinophilia
05/2018 - 01/2017
4Hiatal Hernia
03/2017 - 08/2006
4Carcinogenesis
09/2011 - 07/2004
3Eosinophilic enteropathy
01/2018 - 01/2012
3Hypersensitivity (Allergy)
01/2018 - 08/2013
2Ulcerative Colitis
01/2024 - 05/2022
2Crohn Disease (Crohn's Disease)
01/2024 - 02/2021
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2024 - 01/2006
2Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 04/2015
2Pancreatitis
05/2022 - 06/2006
2Gastritis
06/2021 - 07/2004
2Body Weight (Weight, Body)
03/2021 - 07/2011
2Non-alcoholic Fatty Liver Disease
03/2021 - 01/2018
2Autoimmune enteropathy
08/2020 - 02/2018
2Celiac Disease (Celiac Sprue)
08/2020 - 02/2018
2Atrophy
07/2020 - 03/2017
2Ulcer
04/2018 - 10/2011
2Hepatocellular Carcinoma (Hepatoma)
11/2017 - 07/2006
2Diverticulum
04/2017 - 10/2016
2Gastroenteritis
01/2016 - 01/2012
2Bile Reflux
06/2012 - 09/2011
2Hypoxia (Hypoxemia)
02/2012 - 12/2008
2Chronic Hepatitis C
01/2010 - 01/2003
2Cholangiocarcinoma
01/2006 - 05/2005
2Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2006 - 04/2003
1Esophageal Squamous Cell Carcinoma
12/2024
1Carcinoma (Carcinomatosis)
06/2023
1Nausea
05/2023
1Weight Loss (Weight Reduction)
05/2023
1Anorexia Nervosa
05/2023
1Anorexia
05/2023
1Abdominal Pain (Pain, Abdominal)
05/2023
1Vomiting
05/2023
1Ascites
11/2022
1Esophageal and Gastric Varices (Esophageal Varices)
11/2022
1Portal Hypertension
11/2022
1Renal Cell Carcinoma (Grawitz Tumor)
05/2022
1Hyperplasia
04/2022
1Non-Erosive Reflux Disease
01/2022
1Esophageal Neoplasms (Esophageal Cancer)
06/2021

Drug/Important Bio-Agent (IBA)

14Proton Pump InhibitorsIBA
01/2021 - 06/2007
12AcidsIBA
01/2022 - 06/2007
8Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2008
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021 - 05/2005
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2020 - 07/2004
4LigandsIBA
11/2017 - 11/2004
4CytokinesIBA
11/2017 - 10/2006
4MucinsIBA
09/2011 - 08/2006
3PotassiumIBA
01/2022 - 01/2016
3Immunoglobulin G (IgG)IBA
06/2021 - 06/2019
3Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
06/2021 - 01/2018
3Acetic Acid (Vinegar)FDA LinkGeneric
04/2020 - 04/2015
3Chemokine CCL26IBA
01/2018 - 01/2016
3AllergensIBA
01/2018 - 08/2013
3Bile Acids and Salts (Bile Acids)IBA
03/2016 - 09/2011
3Gentian Violet (Violet, Crystal)FDA Link
04/2015 - 01/2004
3Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2015 - 06/2007
3Toll-Like Receptors (Toll-Like Receptor)IBA
11/2013 - 04/2003
2Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2017
21- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
01/2022 - 07/2021
2ChemokinesIBA
01/2021 - 11/2017
2Glutens (Glutelin)IBA
08/2020 - 02/2018
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2018 - 10/2011
2Z 338IBA
04/2018 - 09/2015
2Interleukin-13IBA
01/2018 - 01/2016
2Interleukin-5 (Interleukin 5)IBA
01/2018 - 01/2016
2Interleukin-15 (Interleukin 15)IBA
01/2018 - 01/2016
2Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
11/2017 - 07/2011
2Messenger RNA (mRNA)IBA
09/2011 - 07/2006
2InterferonsIBA
01/2010 - 01/2003
2NF-kappa B (NF-kB)IBA
01/2006 - 01/2006
2Pattern Recognition ReceptorsIBA
01/2006 - 04/2003
2Dextrans (Dextran)FDA Link
01/2006 - 04/2003
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2006 - 04/2003
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2024
1Phenobarbital (Luminal)FDA Link
06/2023
1IS 23IBA
05/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2022
1Immune Checkpoint InhibitorsIBA
05/2022
1NivolumabIBA
05/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2022
1Tacrolimus (Prograf)FDA LinkGeneric
05/2022

Therapy/Procedure

12Therapeutics
05/2022 - 01/2003
2Lasers (Laser)
04/2022 - 10/2006
2Endoscopes
03/2020 - 01/2018
1General Anesthesia
12/2024
1Drug Therapy (Chemotherapy)
11/2022
1Remission Induction
05/2022
1Diet Therapy (Therapy, Diet)
07/2021